NEW YORK – Artios Pharma said on Thursday that it has begun a Phase I/II clinical trial evaluating its ATR inhibitor, ART0380, alone and together with chemotherapy as a treatment for certain patients with solid cancers.
NEW YORK – Artios Pharma said on Thursday that it has begun a Phase I/II clinical trial evaluating its ATR inhibitor, ART0380, alone and together with chemotherapy as a treatment for certain patients with solid cancers.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.